Menu
Fechar
HRS4R
Vull donar
Firma
JORDI MARRUECOS-QUEROL
Posició
Investigador/a Pre-doctoral – R1
Investigadors/es Pre-doctorals – R1
Publicacions

Publicacions

Rubió-Casadevall J, Ciurana E, Puigdemont M, Sanvisens A, Marruecos J, Miró J, Urban A, Palhua RL, Martín-Romero F, Ortiz-Duran MR, Marcos-Gragera R

Population-Based Analysis of Trends in Incidence and Survival of Human Papilloma Virus-Related Oropharyngeal Cancer in a Low-Burden Region of Southern Europe

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 dx.doi.org/10.3390/ijerph19084802

Humbert-Vidan, L, Hansen, CR, Fuller, CD, Petit, S, Van der Schaaf, A, Van Dijk, LV, Verduijn, GM, Langendijk, H, Munoz-Montplet, C, Heemsbergen, W, Witjes, M, Mohamed, ASR, Khan, AA, Querol, JM, Cancio, IO, Patel, V, King, AP, Johansen, J, Urbano, TG

Protocol Letter: A multi-institutional retrospective case-control cohort investigating PREDiction models for mandibular OsteoRadioNecrosis in head and neck cancer (PREDMORN)

RADIOTHERAPY AND ONCOLOGY, 2022, 176, 99-100 dx.doi.org/10.1016/j.radonc.2022.09.014

Esteve-Codina A, Alameda F, Carrato C, Pineda E, Arpí O, Martinez Garcia M, Mallo M, Gut M, Dabad M, Tortosa A, Del Barco S, Capellades J, Puig J, Gallego O, Pujol T, Oleaga L, Gil-Gil MJ, de Quintana-Schmidt C, Valduvieco I, Martinez-Cardus A, Bellosillo B, Muñoz-Mármol AM, Esteve A, Domenech M, Camins A, Craven-Bartle J, Villa S, Marruecos J, Domenech S, de la Iglesia N, Balana C

RNA sequencing and Immunohistochemistry Reveal ZFN7 as a Stronger Marker of Survival than Molecular Subtypes in G-CIMP-negative Glioblastoma

CLINICAL CANCER RESEARCH, 2021, 27, 645-655 dx.doi.org/10.1158/1078-0432.CCR-20-2141

Rubió-Casadevall J, Galceran J, Ameijide A, Puigdemont M, Llauradó L, Marruecos J, Izquierdo A, Carulla M, Borràs JL, Marcos-Gragera R, Gumà J

Population-based risk assessment of second primary cancers following a first head and neck cancer: patterns of association and difficulties of its analysis

CLINICAL & TRANSLATIONAL ONCOLOGY, 2021, 23, 788-798 dx.doi.org/10.1007/s12094-020-02470-z

Lozano A, Marruecos J, Rubió J, Farré N, Gómez-Millán J, Morera R, Planas I, Lanzuela M, Vázquez-Masedo MG, Cascallar L, Giralt J, Escames G, Valentí V, Grima P, Bosser R, Tarragó C, Mesía R

Randomized placebo-controlled phase II trial of high-dose melatonin mucoadhesive oral gel for the prevention and treatment of oral mucositis in patients with head and neck cancer undergoing radiation therapy concurrent with systemic treatment

CLINICAL & TRANSLATIONAL ONCOLOGY, 2021, 23, 1801-1810 dx.doi.org/10.1007/s12094-021-02586-w

Martínez-Trufero J, Lozano Borbalas A, Pajares Bernad I, Taberna Sanz M, Ortega Izquierdo E, Cirauqui Cirauqui B, Rubió-Casadevall J, Plana Serrahima M, Ponce Ortega JM, Planas Toledano I, Caballero J, Marruecos Querol J, Iglesias Docampo L, Lambea Sorrosal J, Adansa JC, Mesía Nin R, Grupo Español de Tratamiento de Tumores de Cabeza y Cuello (TTCC)

Sequential chemotherapy regimen of induction with panitumumab and paclitaxel followed by radiotherapy and panitumumab in patients with locally advanced head and neck cancer unfit for platinum derivatives. The phase II, PANTERA/TTCC-2010-06 study

CLINICAL & TRANSLATIONAL ONCOLOGY, 2021, 23, 1666-1677 dx.doi.org/10.1007/s12094-021-02567-z

Guerra-Librero A, Fernandez-Gil BI, Florido J, Martinez-Ruiz L, Rodríguez-Santana C, Shen YQ, García-Verdugo JM, López-Rodríguez A, Rusanova I, Quiñones-Hinojosa A, Acuña-Castroviejo D, Marruecos J, De Haro T, Escames G

Melatonin Targets Metabolism in Head and Neck Cancer Cells by Regulating Mitochondrial Structure and Function

Antioxidants, 2021, 10 dx.doi.org/10.3390/antiox10040603

Muñoz-Montplet C, Marruecos J, Buxó M, Jurado-Bruggeman D, Romera-Martínez I, Bueno M, Vilanova JC

Dosimetric impact of Acuros XB dose-to-water and dose-to-medium reporting modes on VMAT planning for head and neck cancer

PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 2018, 55, 107-115 dx.doi.org/10.1016/j.ejmp.2018.10.024

Balaña C, Estival A, Teruel I, Hardy-Werbin M, Sepulveda J, Pineda E, Martinez-García M, Gallego O, Luque R, Gil-Gil M, Mesia C, Del Barco S, Herrero A, Berrocal A, Perez-Segura P, De Las Penas R, Marruecos J, Fuentes R, Reynes G, Velarde JM, Cardona A, Verger E, Panciroli C, Villà S

Delay in starting radiotherapy due to neoadjuvant therapy does not worsen survival in unresected glioblastoma patients

CLINICAL & TRANSLATIONAL ONCOLOGY, 2018, 20, 1529-1537 dx.doi.org/10.1007/s12094-018-1883-7

Balaña C, Capellades J, Pineda E, Estival A, Puig J, Domenech S, Verger E, Pujol T, Martinez-García M, Oleaga L, Velarde J, Mesia C, Fuentes R, Marruecos J, Del Barco S, Villà S, Carrato C, Gallego O, Gil-Gil M, Craven-Bartle J, Alameda F, GLIOCAT Group

Pseudoprogression as an adverse event of glioblastoma therapy.

CANCER MEDICINE, 2017, 6, 2858-2866 dx.doi.org/10.1002/cam4.1242

Formulari de contacte

Coneix l’IDIBGI!

 menu